Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
646
datasets available to search
ShareScore release 0.7.1
Dataset results
646 results for “Pseudomonas aeruginosa”
Figure 14 from: Dorri K, Modaresi F, Shakibaie MR, Moazamian E (2022) Effect of gold nanoparticles on the expression of efflux pump mexA and mexB genes of Pseudomonas aeruginosa strains by Quantitative real-time PCR. Pharmacia 69(1): 125-133. https://doi.org/10.3897/pharmacia.69.e77608
Figure 14 Melting curve analysis to ensure the specificity of the amplified fragments of the MexA gene; the measured curves of the gene in all samples are consistent and in the form of single-peak.
Figure 10 from: Dorri K, Modaresi F, Shakibaie MR, Moazamian E (2022) Effect of gold nanoparticles on the expression of efflux pump mexA and mexB genes of Pseudomonas aeruginosa strains by Quantitative real-time PCR. Pharmacia 69(1): 125-133. https://doi.org/10.3897/pharmacia.69.e77608
Figure 10 Percentage of Pseudomonas aeruginosa isolates carrying gyrB, rhlR, exoT, lasR, Pela, and toxA.
Figure 16 from: Dorri K, Modaresi F, Shakibaie MR, Moazamian E (2022) Effect of gold nanoparticles on the expression of efflux pump mexA and mexB genes of Pseudomonas aeruginosa strains by Quantitative real-time PCR. Pharmacia 69(1): 125-133. https://doi.org/10.3897/pharmacia.69.e77608
Figure 16 Melting curve analysis to ensure the specificity of the amplified fragments of the MexB gene; the measured curves of the gene in all samples are consistent and in the form of single-peak.
Figure 11 from: Dorri K, Modaresi F, Shakibaie MR, Moazamian E (2022) Effect of gold nanoparticles on the expression of efflux pump mexA and mexB genes of Pseudomonas aeruginosa strains by Quantitative real-time PCR. Pharmacia 69(1): 125-133. https://doi.org/10.3897/pharmacia.69.e77608
Figure 11 Results of MexA gene replication in clinical isolates of Pseudomonas aeruginosa. Well 1: marker size 1 kb; Well 2–8: positive samples of size 316 bp; Well 9: positive control of Pseudomonas aeruginosa PTCC 17589.
Figure 12 from: Dorri K, Modaresi F, Shakibaie MR, Moazamian E (2022) Effect of gold nanoparticles on the expression of efflux pump mexA and mexB genes of Pseudomonas aeruginosa strains by Quantitative real-time PCR. Pharmacia 69(1): 125-133. https://doi.org/10.3897/pharmacia.69.e77608
Figure 12 Results of MexB gene replication in clinical isolates of Pseudomonas aeruginosa. Well 6: marker size 1 kb; Well 1–5 and 8–12: positive samples of size 244 bp; Well 7: positive control of Pseudomonas aeruginosa PTCC 17589.
Copper selects for siderophore-mediated virulence in Pseudomonas aeruginosa: data
<p>Data for the paper entitled 'Copper selects for siderophore-mediated virulence in Pseudomonas aeruginosa'. Columns are:</p> <p>- copper: 1 = no copper control, 2 = 0.1g/L copper sulphate, 3 = 1.0g/L copper sulphate.</p> <p>- rep: rep identifier to allow control of repeated sampling</p> <p>- death: the number of larvae dead out of 20</p> <p>- pyo: the amount of pyoverdine in the sample. Values of sterile media are already subtracted from these readings.</p> <p>- od: the optical density of each sample. Values of sterile media are already subtracted from these readings.</p> <p>- tp: timepoint. 1 = 2 days, 2 = 12 days</p> <p>- cfu: the number of colony forming units per 25µL of freezer stock. This is made with 50% glycerol.</p> <p>- strain: wildtype = a pyoverdine and pyochelin producer, mutant = a non-producer</p>
Plant-derived catechols are substrates of TonB-dependent transporters and sensitize Pseudomonas aeruginosa to siderophore-drug conjugates
<p>The dataset contains raw data used to generate the figures of the associated mansucript</p>
Figure 1 in Blue and red light photoemitters as approach to inhibit Staphylococcus aureus and Pseudomonas aeruginosa growth
Figure 1. Effect of blue and red light -exposure on the growth of S. aureus e P. aeruginosa determined by the number of colonies formed after 24 h incubation. *Statistically significant difference using Mann-Whitney U test (p <0.05) for independent samples.
Figure 4 in Phenotypic and molecular characterization of fluoroquinolone resistant Pseudomonas aeruginosa isolates in Palestine
Figure 4. Amino acid variation positions of GyrA (A),ParC (B) and ParE (C) genes among the studied fluoroquinolone resistant P.aeruginosa isolates according to the references from GenBank.
Quorum sensing inhibitor against Pseudomonas aeruginosa biofilm
Open the record for dataset details and reuse information.
Pseudomonas aeruginosa - hashed WhatsGNU basic database
<p>WhatsGNU hashed basic database for <em>Pseudomonoas aeruginosa. </em></p>
Data from: Temporal variation in antibiotic environments slows down resistance evolution in pathogenic Pseudomonas aeruginosa
Antibiotic resistance is a growing concern to public health. New treatment strategies may alleviate the situation by slowing down the evolution of resistance. Here, we evaluated sequential treatment protocols using two fully independent laboratory-controlled evolution experiments with the human pathogen Pseudomonas aeruginosa PA14 and two pairs of clinically relevant antibiotics (doripenem/ciprofloxacin and cefsulodin/gentamicin). Our results consistently show that the sequential application of two antibiotics decelerates resistance evolution relative to monotherapy. Sequential treatment enhanced population extinction although we applied antibiotics at sub-lethal dosage. In both experiments, we identified an order-effect of the antibiotics used in the sequential protocol, leading to significant variation in the long-term efficacy of the tested protocols. These variations appear to be caused by asymmetric evolutionary constraints, whereby adaptation to one drug slowed down adaptation to the other drug, but not vice versa. An understanding of such asymmetric constraints may help future development of evolutionary robust treatments against infectious disease.
Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection
ClinicalTrials.gov study NCT05616221. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA)
ClinicalTrials.gov study NCT00128492. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Detection of Pseudomonas Aeruginosa in the Airways of Patients With CF
ClinicalTrials.gov study NCT01303068. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis
ClinicalTrials.gov study NCT04596319. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety of AZLI in Children With Cystic Fibrosis (CF) and Chronic Pseudomonas Aeruginosa in the Lower Airways
ClinicalTrials.gov study NCT01404234. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.
ClinicalTrials.gov study NCT00775138. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Bacteriophage Clinical Trial for Periprosthetic Joint Infection of Multidrug Resistant Pseudomonas Aeruginosa
ClinicalTrials.gov study NCT06798168. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Data from: Selection experiments reveal trade-offs between swimming and twitching motilities in Pseudomonas aeruginosa
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.